Clinical Trial Update: Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant [NA]

View source ↗

Summary

An exploratory trial evaluating the immune response to early PCV13 vaccination (Prevnar 13) given with autologous stem cell transplant in multiple myeloma; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Multiple Myeloma | NA | Status: COMPLETED | Results posted: 2016-04-04